SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of ...
Last weekend a sizeable number of developers and industry professionals descended upon Seattle for Unite 2014, a major gathering focused on the widely used Unity development engine. Nintendo's Unity ...
SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UBX) (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...
John Riccitiello opened his company's GDC 2017 keynote in much the same style he has every major Unity presentation over the past few years: reiterating the company's three goals, one of which is ...
Title: Effect of Patient Baseline Characteristics on Response to UBX1325, a Novel Senolytic Candidate For Patients With DME: BEHOLD Phase 2 Study 48 weeks follow-up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback